Lee, S. J., Kim, T. M., Kim, Y. J., Jang, K., Lee, H. J., Lee, S. N., . . . Lee, J. (2015). Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06). Oncologist.
Style de citation ChicagoLee, Su Jin, et al. "Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06)." Oncologist 2015.
Style de citation MLALee, Su Jin, et al. "Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06)." Oncologist 2015.
Attention : ces citations peuvent ne pas être correctes à 100%.